Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model
Article in Frontiers in Immunology (March 2024)
The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
Article in JAMA Network Open (March 2024)
Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand?
Article in Biomedicines (February 2024)